Swiss - Delayed Quote CHF

medmix AG (MEDX.SW)

Compare
9.71 -0.05 (-0.51%)
At close: 5:31 PM GMT+1
Currency in CHF All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
486,600.00
486,600.00
477,100.00
457,300.00
351,300.00
Cost of Revenue
328,900.00
328,900.00
301,700.00
276,100.00
230,200.00
Gross Profit
157,600.00
157,600.00
175,400.00
181,200.00
121,100.00
Operating Expense
143,400.00
143,400.00
125,900.00
118,300.00
100,700.00
Operating Income
14,200.00
14,200.00
49,500.00
62,900.00
20,400.00
Net Non Operating Interest Income Expense
-9,900.00
-9,900.00
-5,600.00
-8,400.00
-7,600.00
Pretax Income
2,900.00
2,900.00
12,200.00
51,300.00
10,500.00
Tax Provision
2,200.00
2,200.00
600.00
7,300.00
800.00
Net Income Common Stockholders
300.00
300.00
11,600.00
44,000.00
9,600.00
Diluted NI Available to Com Stockholders
300.00
300.00
11,600.00
44,000.00
9,600.00
Basic EPS
0.01
--
0.28
1.07
0.23
Diluted EPS
0.01
--
0.28
1.07
0.23
Basic Average Shares
40,868.43
--
40,957.74
41,161.44
41,262.37
Diluted Average Shares
41,203.69
--
41,100.02
41,161.44
41,262.37
Total Operating Income as Reported
16,000.00
16,000.00
19,600.00
59,900.00
18,100.00
Total Expenses
472,300.00
472,300.00
427,600.00
394,400.00
330,900.00
Net Income from Continuing & Discontinued Operation
300.00
300.00
11,600.00
44,000.00
9,600.00
Normalized Income
-1,255.50
-1,255.50
34,186.20
43,828.60
12,816.50
Interest Income
1,400.00
1,400.00
700.00
--
200.00
Interest Expense
10,100.00
10,100.00
6,400.00
8,100.00
7,700.00
Net Interest Income
-9,900.00
-9,900.00
-5,600.00
-8,400.00
-7,600.00
EBIT
13,000.00
13,000.00
18,600.00
59,400.00
18,200.00
EBITDA
71,400.00
71,400.00
69,700.00
111,100.00
61,300.00
Reconciled Cost of Revenue
328,900.00
328,900.00
301,700.00
276,100.00
230,200.00
Reconciled Depreciation
58,400.00
58,400.00
51,100.00
51,700.00
43,100.00
Net Income from Continuing Operation Net Minority Interest
300.00
300.00
11,600.00
44,000.00
9,600.00
Total Unusual Items Excluding Goodwill
1,700.00
1,700.00
-23,800.00
200.00
-3,500.00
Total Unusual Items
1,700.00
1,700.00
-23,800.00
200.00
-3,500.00
Normalized EBITDA
69,700.00
69,700.00
93,500.00
110,900.00
64,800.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
144.50
144.50
-1,213.80
28.60
-283.50
12/31/2020 - 10/4/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers